You don't need to be signed in to listen to BMJ Group Podcasts, but you can register here to receive updates about other BMJ Group products and services via our Group site.

End of life

20 Nov, 09 | by BMJ Group

In the UK, death is a subject we steer clear of. Talking with a patient about the end of their life is uncomfortable, but necessary. A recent report from NCEPOD (the National Confidential Enquiry into Patient Outcome and Death) called “Caring to the End” has highlighted why this conversation needs to improve. We hear from David Mason, one of the clinical coordinators for the report, about their findings.

Also this week, when end of life care hits the headlines it is almost inevitably about assisted dying. We hear about times when doctors in Switzerland or the Netherlands help a patient to die, but what about when they refuse?  Roeline Pasman and Dick Williems join us to discuss their study into the ways in which patients’ ideas of unbearable suffering may differ from their doctors’ ideas.

Birte Twisselmann takes us through this week’s news.

See also;
Concept of unbearable suffering in context of ungranted requests for euthanasia.
Deaths in Acute Hospitals: Caring to the End?

End of life [24:48m]:

Monitoring modernisation

13 Nov, 09 | by BMJ Group

Home fetal heart monitors can help prospective parents bond with their babies, but do they offer false reassurance when things go wrong? In this week’s podcast Rebecca Coombes hears a cautionary tale from Abhijoy Chakladar, from Princess Royal Hospital in West Sussex.

Also this week, the NHS Modernisation Agency has been tasked with improving care for patients. Andrew Hutchings, from the London School of Hygiene and Tropical Medicine, tells us about his analysis of how effective the agency’s adult critical care initiative has been.

David Payne takes us through this week’s news.

See also;
Evaluation of modernisation of adult critical care services in England
Dangers of listening to the fetal heart at home

Monitoring modernisation [18:16m]:

Analysing aspirin

6 Nov, 09 | by BMJ Group

BMJ deputy editor Trish Groves interviews Ike Iheanacho, editor of Drug and Therapeutics Bulletin, about its report on the use of aspirin as a primary preventative. Kirsten Patrick, an associate editor at the BMJ, talks to Charis Eng from the Cleveland Clinic about the growth in commercially available genomic screening tests. And Sabreena Malik, clinical community editor of doc2doc, BMJ Group’s clinical community site, takes us through this week’s news.

See also;

Aspirin for primary prevention of cardiovascular disease?
A practical guide to interpretation and clinical application of personal genomic screening

Analysing aspirin [19:24m]:

Tuberculosis in East Timor

30 Oct, 09 | by BMJ Group

This week Duncan Jarvies talks to Paul Kelly about treating TB in East Timor, and to Kevin Deans about the link between deprivation and heart disease in Glasgow. Annabel Ferriman takes us through this week’s news.

See also;

Differences in atherosclerosis according to area level socioeconomic deprivation
Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste

Tuberculosis in East Timor [21:29m]:

Want and no more, need and no less

23 Oct, 09 | by BMJ Group

Political attention has been focused on providing universal health cover, but this can’t happen without curbing rising costs. In this week’s podcast Duncan Jarvies talks to Albert Mulley, from Massachusetts General Hospital and Harvard Medical School, about how practice variation is driving up the cost of health care. Zosia Kmietowicz takes us through the news.

See also;

Inconvenient truths about supplier induced demand and unwarranted variation in medical practice

Want and no more, need and no less [18:17m]:

SIDS and SSRIs

16 Oct, 09 | by BMJ Group

This week Duncan Jarvies talks to Peter Fleming about his latest findings into the risk factors for SIDS. He also finds out from Michael Moore about what’s causing the rise in antidepressant prescription in the UK. Birte Twisselmann takes us through the news.

See also;
Risk factors for SIDS
Explaining the rise in antidepressant prescribing

SIDS and SSRIs [17:05m]:

Tumour markers and HPV vaccination

9 Oct, 09 | by BMJ Group

This week Kirsten Patrick talks to Cathie Sturgeon about the usefulness of tumour markers, Birte Twisselmann finds out from Jane Kim the cost effectiveness of vaccinating boys against HPV, and Deborah Cohen takes us through this week’s highlights.

See also;
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
Serum tumour markers: how to order and interpret them
The cost of donated drugs

Tumour markers and HPV vaccination [16:31m]:

Statins, kidney disease, and preventing abuse

2 Oct, 09 | by BMJ Group

This week Duncan Jarvies talks to Ben Reis, from Harvard Medical School, about using longitudinal histories to predict domestic abuse. Mabel Chew finds out from Charlie Tomson about the evidence behind using statins in patients with kidney disease, and Annabel Ferriman takes us though the news.

See also:

Longitudinal histories as predictors of future diagnoses of domestic abuse: modelling study

Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?

Detecting abuse and statins [18:02m]:

Dignified dying and physical barriers

25 Sep, 09 | by BMJ Group

This week Zosia Kmietowicz talks to Keir Starmer QC, the Director of Public Prosecutions, about the clarification on the law for assisted suicide. Deborah Cohen finds out from NCAS (the National Clinical Assessment Service) about their recent report into the types of doctors most often referred to them, and Duncan Jarvies talks to Tom Jefferson about how effective physical barriers are at preventing the spread of respiratory viruses.
See also:
Physical interventions to interrupt or reduce the spread of respiratory viruses
Male doctors, doctors over 50, and doctors qualifying overseas are more likely to raise concerns about performance
The Crown Prosecution Service

Dignified dying and physical barriers [20:01m]:

New problems, old problems

11 Sep, 09 | by BMJ Group

This week Duncan Jarvies talks to Vivienne Nathanson from the BMA and Gerard Hastings from Stirling University and the Open University about the BMA’s plans to take on alcohol advertising. Birte Twisselmann finds out from Ian Gregory about the UK’s legacy of deprivation, and David Payne takes us through what’s new online.

See also:

Under the influence - the damaging effect of alcohol marketing on young people
doc2doc forum: Should alcohol advertising be banned?
Comparisons between geographies of mortality and deprivation from the 1900s and 2001

New problems, old problems:

Latest from BMJ.com

Latest from BMJ.com

Latest BMJ blogs

Latest BMJ blogs